Who owns Dare Bioscience, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of DARE from SEC Form 13F filings across 38 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 38 institutions disclosed 1.7M shares of Dare Bioscience, Inc. worth $1.5M — about 10% of shares outstanding; the largest disclosed holder is VANGUARD CAPITAL MANAGEMENT LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
38
13F holders
$1.5M
value, 2026 filers
10%
of shares outstanding (1.7M sh)
14
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of DARE's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 632,871 | $539,839 | 0.0% | 3.6% | -1.2% |
| 2 | UBS Group AG | 239,597 | $204,377 | 0.0% | 1.4% | +3418.3% |
| 3 | US BANCORP \DE\ | 220,920 | $188,511 | 0.0% | 1.3% | +82.7% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 152,405 | $130,065 | 0.0% | 0.9% | +8.8% |
| 5 | VANGUARD FIDUCIARY TRUST CO | 91,269 | $77,852 | 0.0% | 0.5% | 0.0% |
| 6 | BlackRock, Inc. | 62,162 | $53,043 | 0.0% | 0.4% | -3.2% |
| 7 | STATE STREET CORP | 47,415 | $40,459 | 0.0% | 0.3% | 0.0% |
| 8 | CITADEL ADVISORS LLCNEW | 45,142 | $38,520 | 0.0% | 0.3% | new |
| 9 | XTX Topco LtdNEW | 37,376 | $31,893 | 0.0% | 0.2% | new |
| 10 | HRT FINANCIAL LP | 37,342 | $31,000 | 0.0% | 0.2% | +66.5% |
| 11 | NORTHERN TRUST CORP | 34,209 | $29,191 | 0.0% | 0.2% | 0.0% |
| 12 | Virtu Financial LLC | 33,506 | $29,000 | 0.0% | 0.2% | +112.0% |
| 13 | TWO SIGMA SECURITIES, LLCNEW | 19,656 | $16,772 | 0.0% | 0.1% | new |
| 14 | Garde Capital, Inc.NEW | 16,220 | $13,841 | 0.0% | 0.1% | new |
| 15 | LPL Financial LLC | 14,889 | $12,705 | 0.0% | 0.1% | 0.0% |
| 16 | RAYMOND JAMES FINANCIAL INC | 14,628 | $12,483 | 0.0% | 0.1% | -1.6% |
| 17 | PRICE T ROWE ASSOCIATES INC /MD/ | 13,318 | $12,000 | 0.0% | 0.1% | 0.0% |
| 18 | Objectivity Squared, LLC | 10,915 | $9,314 | 0.0% | 0.1% | 0.0% |
| 19 | Farther Finance Advisors, LLC | 9,408 | $8,028 | 0.0% | 0.1% | -0.4% |
| 20 | Vanguard Global Advisers, LLC | 2,940 | $2,508 | 0.0% | 0% | 0.0% |
| 21 | Tower Research Capital LLC (TRC)NEW | 1,733 | $1,479 | 0.0% | 0% | new |
| 22 | PNC Financial Services Group, Inc.NEW | 1,100 | $938 | 0.0% | 0% | new |
| 23 | IFS Advisors, LLC | 950 | $810 | 0.0% | 0% | 0.0% |
| 24 | SBI Securities Co., Ltd. | 715 | $610 | 0.0% | 0% | +10.9% |
| 25 | ROYAL BANK OF CANADANEW | 596 | $1,000 | 0.0% | 0% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.